Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

被引：326

作者：

Hershberger, Ray E. ^{[1
]}

Lindenfeld, Joann ^{[2
]}

Mestroni, Luisa ^{[2
,3
]}

Seidman, Christine E. ^{[4
,5
]}

Taylor, Matthew R. G. ^{[2
,3
]}

Towbin, Jeffrey A. ^{[6
]}

机构：

[1] Univ Miami, Sch Med, Div Cardiovasc, Miami, FL 33101 USA

[2] Univ Colorado, Hlth Sci Ctr, Div Cardiol, Denver, CO 80262 USA

[3] Univ Colorado, Hlth Sci Ctr, Adult Med Genet Program, Denver, CO 80262 USA

[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA

[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Genet Ctr, Boston, MA 02115 USA

[6] Baylor Coll Med, Div Pediat Cardiol, Houston, TX 77030 USA

来源：

JOURNAL OF CARDIAC FAILURE | 2009年 / 15卷 / 02期

关键词：

RIGHT-VENTRICULAR CARDIOMYOPATHY; LAMIN-A/C GENE; MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-I; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; X-LINKED GENE; DILATED CARDIOMYOPATHY; CONDUCTION-SYSTEM; ACTIN GENE; MUTATIONAL ANALYSIS;

D O I：

10.1016/j.cardfail.2009.01.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and left ventricular noncompaction (LVNC). HCM, DCM, and RCM have been recognized as distinct clinical entities for decades, whereas ARVD/C and LVNC are relative newcomers to the field. Hence the clinical and genetic knowledge for each cardiomyopathy varies, as do the recommendations and strength of evidence. (J Cardiac Fail 2009;15:83-97)

引用

页码：83 / 97

页数：15

共 111 条

[1] Executive summary:: HFSA 2006 comprehensive heart failure practice guideline [J].

Adams, KF ;

Lindenfeld, J ;

Arnold, JMO ;

Baker, DW ;

Barnard, DH ;

Baughman, KL ;

Boehmer, JP ;

Deedwania, P ;

Dunbar, SB ;

Elkayam, U ;

Gheorghiade, M ;

Howlett, JG ;

Konstam, MA ;

Kronenberg, MW ;

Massie, BM ;

Mehra, MR ;

Miller, AB ;

Moser, DK ;

Patterson, JH ;

Rodeheffer, RJ ;

Sackner-Bernstein, J ;

Silver, MA ;

Starling, RC ;

Stevenson, LW ;

Wagoner, LE ;

Francis, GS ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Greenberg, BH ;

Force, T ;

Krumholz, HM ;

Liu, PP ;

Mann, DL ;

Piña, IL ;

Pressler, SJ ;

Sabbah, HN ;

Yancy, CW .

JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :10-38

[2] Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis [J].

Antoniades, Loizos ;

Tsatsopoulou, Adalena ;

Anastasakis, Aris ;

Syrris, Petros ;

Asimaki, Angeliki ;

Panagiotakos, Demosthenes ;

Zambartas, Costas ;

Stefanadis, Christodoulos ;

McKenna, William J. ;

Protonotarios, Nikos .

EUROPEAN HEART JOURNAL, 2006, 27 (18) :2208-2216

[3] Glycogen storage diseases presenting as hypertrophic cardiomyopathy [J].

Arad, M ;

Maron, BJ ;

Gorham, JM ;

Johnson, WH ;

Saul, JP ;

Perez-Atayde, AR ;

Spirito, P ;

Wright, GB ;

Kanter, RJ ;

Seidman, CE ;

Seidman, JG .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :362-372

[4] Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy [J].

Arad, M ;

Benson, DW ;

Perez-Atayde, AR ;

McKenna, WJ ;

Sparks, EA ;

Kanter, RJ ;

McGarry, K ;

Seidman, JG ;

Seidman, CE .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :357-362

[5] Autosomal dominant dilated cardiomyopathy with atrioventricular block: A lamin A/C defect-related disease [J].

Arbustini, E ;

Pilotto, A ;

Repetto, A ;

Grasso, M ;

Negri, A ;

Diegoli, M ;

Campana, C ;

Scelsi, L ;

Baldini, E ;

Gavazzi, A ;

Tavazzi, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (06) :981-990

[6] DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].

Awad, Mark M. ;

Dalal, Darshan ;

Cho, Eunpi ;

Amat-Alarcon, Nuria ;

James, Cynthia ;

Tichnell, Crystal ;

Tucker, April ;

Russell, Stuart D. ;

Bluemke, David A. ;

Dietz, Harry C. ;

Calkins, Hugh ;

Judge, Daniel P. .

AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (01) :136-142

[7] High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation [J].

Bécane, HM ;

Bonne, G ;

Varnous, S ;

Muchir, A ;

Ortega, V ;

Hammouda, E ;

Urtizberea, JA ;

Lavergne, T ;

Fardeau, M ;

Eymard, B ;

Weber, S ;

Schwartz, K ;

Duboc, D .

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11) :1661-1666

[8] Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1 [J].

Beffagna, G ;

Occhi, G ;

Nava, A ;

Vitiello, L ;

Ditadi, A ;

Basso, C ;

Bauce, B ;

Carraro, G ;

Thiene, G ;

Towbin, JA ;

Danieli, GA ;

Rampazzo, A .

CARDIOVASCULAR RESEARCH, 2005, 65 (02) :366-373

[9] Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors [J].

Berg, Alfred O. ;

Piper, Margaret ;

Armstrong, Katrina ;

Botkin, Jeffrey ;

Calonge, Ned ;

Haddow, James ;

Hayes, Maxine ;

Kaye, Celia ;

Phillips, Kathryn A. ;

Richards, Carolyn Sue ;

Scott, Joan A. ;

Strickland, Ora L. ;

Teutsch, Steven .

GENETICS IN MEDICINE, 2007, 9 (12) :819-825

[10] ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating [J].

Bienengraeber, M ;

Olson, TM ;

Selivanov, VA ;

Kathmann, EC ;

O'Cochlain, F ;

Gao, F ;

Karger, AB ;

Ballew, JD ;

Hodgson, DM ;

Zingman, LV ;

Pang, YP ;

Alekseev, AE ;

Terzic, A .

NATURE GENETICS, 2004, 36 (04) :382-387

← 1 2 3 4 5 6 7 8 9 10 →